Client News

GBA Group Pharma: LKF focuses on SARS-CoV-2 analysis: Ongoing COVID-19 testing to maintain clinical studies

APEIRON Biologics announces financing round for the further development of the COVID-19 drug APN01

Abivax SA: €36 million non-dilutive funding from Bpifrance for Abivax’ ABX464 Covid-19 program

AiCuris unterstützt das Land NRW bei der COVID-19 Ausbruchsbekämpfung in Schlachtbetrieben

Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Program

Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial

Abivax SA: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model

4basebio AG reports first quarter 2020 financial results

CENTOGENE AG: Blaupause für die Bundesrepublik – CENTOGENE ermöglicht Coronavirus-Tests am Gymnasium Neustrelitz

CENTOGENE Announces Global Expansion of COVID-19 Testing